Given that autophagy induction contrasts IR under diabetic conditions, Wan Zhou et al. hypothesized that rapamycin, a specific mTOR inhibitor, could promote autophagy to inhibit IR in T2DM [29]. The gene discussed is MTOR; the disease is type 2 diabetes mellitus.